Updated On: 28 November, 2020 09:15 PM IST | Mumbai | IANS
PM Modi said that 50-60 per cent of the worlds vaccines are made in India and with Atmanirbhar Bharat in mind, SII today showcased the largest pandemic facility at their facility in Pune

Adar Poonawalla
The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks.
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation.